Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of schizophrenia or schizoaffective disorder (based on screening tests)
Medically stable for 1 month and psychiatrically stable without symptom exacerbation for 6 weeks prior to baseline
On stable treatment with a maximum of 2 antipsychotics
You may not be if
Change in regimen for any psychotropic or sleep medication within 1 month
Treatment with more than (\>) 1 mood stabilizer or antidepressant
Use of clozapine within 2 months
Bipolar disorder, or more than mild anxiety disorder
Clareo Health | A Study of the Effect of RO4917838 on Biomarker Measures of Cognitive Dysfunction in Participants With Schizophrenia and Schizoaffective Disorder
